glp-1 receptor agonist type 1 diabetes trial liraglutide GLP-1: Genetic Variants Related to RA Medications GLP-1 receptor agonists in the

GLP-1 receptor agonists (GLP-1RAs) are widely used in the treatment of type 2 diabetes (T2DM) due to their attributes such as body weight loss, protection of islet cells, promotion of islet cell proliferation, and minimal side effects

Back Edwards, K, Li, X, Linvay, I (1 April 2023) 'Clinical and safety outcomes with GLP-1 receptor agonists and SGLT2 inhibitors in type 1 diabetes: A real-world study', The Journal of Clinical Endocrinology & Metabolism , 108/ 4, 92030

In a recent review of GLP-1 RA patient preferences, important attributes driving patient choice included dose frequency, device characteristics (including type of device and needle size), change in HbA1c, and adverse event profile [124]

Piao L, Zhao G, Zhu E, Inoue A, Shibata R, Lei Y, Hu L, Yu C, Yang G, Wu H

BPA and BPS exposure have been tied in numerous studies to metabolic dysfunction and obesity